8037.HK Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 02:52):

China Biotech Services Holdings Limited, an investment holding company, provides medical laboratory testing and health check services in the People's Republic of China and Hong Kong...

Stats
Today's Volume	65 000.00
Average Volume	146 740
Market Cap	255.26M
EPS	HKD0 ( 2024-03-28 )
Last Dividend	HKD0.0100 ( 2023-05-19 )
Next Dividend	HKD0 ( N/A )
P/E	-2.65
ATR14	HKD0 (0.00%)

China Biotech Services Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

China Biotech Services Financials

Annual	2023
Revenue:	HKD211.99M
Gross Profit:	HKD34.32M (16.19 %)
EPS:	HKD-0.0991

Q4	2023
Revenue:	HKD29.63M
Gross Profit:	HKD-27.00M (-91.14 %)
EPS:	HKD-0.0674

Q3	2023
Revenue:	HKD18.36M
Gross Profit:	HKD-11.40M (-62.12 %)
EPS:	HKD-0.0368

Q2	2023
Revenue:	HKD51.80M
Gross Profit:	HKD12.17M (23.49 %)
EPS:	HKD-0.0157

Financial Reports:

No articles found.

China Biotech Services Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0.0100 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

China Biotech Services Dividend Information - No Dividend Player

Dividend Sustainability Score: 1.954 - low (50.00%) | Divividend Growth Potential Score: 2.93 - Decrease likely (41.44%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	HKD0.395	2004-08-19
Last Dividend	HKD0.0100	2023-05-19
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	2	--
Total Paid Out	HKD0.405	--
Avg. Dividend % Per Year	0.00%	--
Score	0.95	--
Div. Sustainability Score	1.954
Div.Growth Potential Score	2.93
Div. Directional Score	2.44	--

Next Divdend (Est)
(2041-12-30)

HKD0 Estimate 2.53 %

Dividend Stability

0.20 Very Poor

Dividend Score

0.95

Pay Frequency

Sporadic

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
3692.HK	Ex Dividend Knight	2023-09-15	Semi-Annually	0.00%
1658.HK	Ex Dividend Junior	2023-07-05	Annually	0.00%
0697.HK	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
9999.HK	Ex Dividend Knight	2023-09-07	Quarterly	0.00%
2217.HK	Ex Dividend Junior	2023-08-15	Annually	0.00%
1223.HK	No Dividend Player	2023-06-27	Sporadic	0.00%
0297.HK	Ex Dividend Junior	2023-06-23	Sporadic	0.00%
3969.HK	Ex Dividend Junior	2023-06-14	Annually	0.00%
1789.HK	Ex Dividend Junior	2023-06-21	Annually	0.00%
0829.HK	Ex Dividend Junior	2023-06-02	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.535	1.500	-10.00	-10.00	[0 - 0.5]
returnOnAssetsTTM	-0.186	1.200	-6.21	-7.45	[0 - 0.3]
returnOnEquityTTM	-0.203	1.500	-3.36	-5.04	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.638	0.800	6.81	5.45	[1 - 3]
quickRatioTTM	1.543	0.800	5.63	4.50	[0.8 - 2.5]
cashRatioTTM	1.297	1.500	3.90	5.85	[0.2 - 2]
debtRatioTTM	0.152	-1.500	7.47	-10.00	[0 - 0.6]
interestCoverageTTM	-34.51	1.000	-10.00	-10.00	[3 - 30]
operatingCashFlowPerShareTTM	0.506	2.00	9.83	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.506	2.00	9.75	10.00	[0 - 20]
debtEquityRatioTTM	0.217	-1.500	9.13	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.0995	1.000	-1.675	-1.675	[0.2 - 0.8]
operatingProfitMarginTTM	-0.796	1.000	-10.00	-10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	4.86	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	0.348	0.800	-1.015	-0.812	[0.5 - 2]
Total Score				1.954

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-2.15	1.000	-0.318	0	[1 - 100]
returnOnEquityTTM	-0.203	2.50	-2.16	-5.04	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.506	2.00	9.83	10.00	[0 - 30]
dividendYielPercentageTTM	3.64	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.506	2.00	9.83	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0	1.500	-3.33	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	2.12	1.000	10.00	0	[0.1 - 0.5]
Total Score				2.93

China Biotech Services

China Biotech Services Holdings Limited, an investment holding company, provides medical laboratory testing and health check services in the People's Republic of China and Hong Kong. The company operates through five segments: Immunotherapy, Pharmaceutical Products, Medical and Health Related Services, Securities, Insurance brokerage, and Others segments. It also engages in the research, development, manufacture, sale, and distribution of health related and pharmaceutical products; trading of securities; money lending business; provision of tumor immune cell therapy, immune cell storage, and health management services; and provision of coordination of healthcare providers services. In addition, the company markets and sells health supplements, slimming pills, Chinese medicines, and beauty products; trades in pharmaceutical intermediates; and offers insurance brokerage services. Further, it provides property investment and logistic services. The company was formerly known as Rui Kang Pharmaceutical Group Investments Limited and changed its name to China Biotech Services Holdings Limited in November 2017. China Biotech Services Holdings Limited was founded in 1996 and is headquartered in Causeway Bay, Hong Kong.